RT Journal Article
SR Electronic
T1 Validity and Reliability of the Assessment of Burden of Chronic Conditions Scale in the Netherlands
JF The Annals of Family Medicine
JO Ann Fam Med
FD American Academy of Family Physicians
SP 103
OP 111
DO 10.1370/afm.2954
VO 21
IS 2
A1 Danny Claessens
A1 Esther A. Boudewijns
A1 Lotte C. E. M. Keijsers
A1 Annerika H. M. Gidding-Slok
A1 Bjorn Winkens
A1 Onno C. P. van Schayck
YR 2023
UL http://www.annfammed.org/content/21/2/103.abstract
AB PURPOSE The Assessment of Burden of Chronic Conditions (ABCC) tool was developed to improve care by facilitating shared decision making and self-management. It assesses and visualizes the experienced burden of 1 or multiple chronic conditions and integrates it in daily care. The aim of this study is to evaluate whether the ABCC scale is valid and reliable in people with chronic obstructive pulmonary disease (COPD), asthma, or type 2 diabetes (T2D).METHODS The Saint George Respiratory Questionnaire (SGRQ), the Standardized Asthma Quality of Life Questionnaire (AQLQ-S), and the Audit of Diabetes Dependent Quality of Life Questionnaire (ADDQoL19) were compared with the ABCC scale to assess convergent validity. The internal consistency was evaluated using Cronbach’s α. Test-retest reliability was evaluated at a 2-week interval.RESULTS A total of 65 people with COPD, 62 with asthma, and 60 with T2D were included. The ABCC scale correlated, in accordance with hypotheses, with the SGRQ (75% of correlations ≥0.7), AQLQ-S (100%), and ADDQoL19 (75%). The ABCC scale was internally consistent with a Cronbach’s α of 0.90, 0.92, and 0.91 for the total score for people with COPD, asthma, and T2D, respectively. The ABCC scale had a good test-retest reliability with an intraclass correlation coefficient of 0.95, 0.93, and 0.95 for people with COPD, asthma, and T2D, respectively.CONCLUSIONS The ABCC scale is a valid and reliable questionnaire that can be used within the ABCC tool for people with COPD, asthma, or T2D. Future research should indicate whether this applies to people with multimorbidity, and what the effects and experiences are upon clinical use.